The store will not work correctly when cookies are disabled.
4-((5-Fluoropyridin-3-yl)oxy)-6-methyl-N-(4-methylthiazol-2-yl)-picolinamide
ID: ALA4093386
PubChem CID: 137653256
Max Phase: Preclinical
Molecular Formula: C16H13FN4O2S
Molecular Weight: 344.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(Oc2cncc(F)c2)cc(C(=O)Nc2nc(C)cs2)n1
Standard InChI: InChI=1S/C16H13FN4O2S/c1-9-3-12(23-13-4-11(17)6-18-7-13)5-14(19-9)15(22)21-16-20-10(2)8-24-16/h3-8H,1-2H3,(H,20,21,22)
Standard InChI Key: LXFZGMMUMWNUIT-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
11.5466 -11.4448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5454 -12.2643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2535 -12.6733 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9631 -12.2638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9603 -11.4412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2517 -11.0359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2492 -10.2187 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9557 -9.8080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6625 -10.2169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3685 -9.8068 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3665 -8.9888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6526 -8.5825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9496 -8.9948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6715 -12.6713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6728 -13.4885 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3785 -12.2616 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0869 -12.6691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1717 -13.4798 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.9713 -13.6484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3788 -12.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8310 -12.3337 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1914 -12.8532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6473 -7.7653 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.8374 -12.6723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
4 14 1 0
14 15 2 0
14 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 2 0
20 22 1 0
12 23 1 0
2 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 344.37 | Molecular Weight (Monoisotopic): 344.0743 | AlogP: 3.73 | #Rotatable Bonds: 4 |
Polar Surface Area: 77.00 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.29 | CX Basic pKa: 2.67 | CX LogP: 2.26 | CX LogD: 2.26 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.78 | Np Likeness Score: -2.13 |
References
1. Felts AS, Rodriguez AL, Blobaum AL, Morrison RD, Bates BS, Thompson Gray A, Rook JM, Tantawy MN, Byers FW, Chang S, Venable DF, Luscombe VB, Tamagnan GD, Niswender CM, Daniels JS, Jones CK, Conn PJ, Lindsley CW, Emmitte KA.. (2017) Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation., 60 (12): [PMID:28530802] [10.1021/acs.jmedchem.7b00410] |